Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03770260
Title Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

multiple myeloma


Ixazomib + MLN4924

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Yale University New Haven Connecticut 06520 United States Details
Moffitt Cancer Center-International Plaza Tampa Florida 33607 United States Details
Moffitt Cancer Center - McKinley Campus Tampa Florida 33612 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from for the field